Cellular Biomedicine Group’s CAR-T License Agreement With Janssen

Janssen advised Cellular Biomedicine Group CAR-T on the transaction.Cellular Biomedicine Group signed an exclusive collaboration and license agreement with Janssen Biotech, Inc., pursuant to which Janssen will…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here